Using a mouse model of T-ALL, we found that the PERK-eIF2-ATF4-JAG1 axis is robustly activated in the BM of mice developing leukemia, a process dependent on the activity associated with leukemia released small extracellular vesicles (SEVs) that activate PERK. Here, JAG1 is linked to leukemia.